Lubberman F, Gelderblom H, Hamberg P, et al. A reduced pazopanib dose with food: Is it more patient-friendly and does it reduce drug costs? ASCO Annual Meeting 2019, abstract 4564.
Mutaties in ESR1 in circulerend tumor-DNA van patiënten met mammacarcinoom: klinische betekenis
dec 2017 | Borstkanker